Company
Transcode Therapeutics, Inc. (RNAZ)
Standardized SEC financial data for Transcode Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001829635 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-335.4%
Free cash flow
-$19.5M
Current ratio
6.29×
EPS (diluted)
$-52.59
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $284K | $2.8M | $10.2M | $12.3M | $9.7M | $13.4M |
| SG&A expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $828K | $20.8M | $5.0M | $2.8M | $5.8M | $17.8M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$493K | -$5.3M | -$15.8M | -$18.1M | -$13.3M | -$19.5M |
| Capital expenditures |
Get RNAZ data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/RNAZ/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/RNAZ/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"